Exploring the Future of Longevity Medicine at CALM 2027 Conference in Florida
The realm of longevity medicine is rapidly evolving, presenting an array of therapies, technologies, and initiatives that aim to extend healthy life and improve overall well-being. The CALM 2027 conference, organized by nuBioAge, will take place on February 19–20, 2027, at the Omni in Fort Lauderdale, Florida, placing its emphasis on enhancing the role of practitioners in this burgeoning field.
As the industry becomes more consumer-focused, the necessity for medical professionals to stay ahead of developments is paramount. CALM, which stands for the Clinical Application of Longevity Medicine, is tailored specifically for healthcare providers such as physicians, nurse practitioners, pharmacists, and clinical leaders tasked with implementing longevity medicine into their practices. The conference is designed to equip these practitioners with the knowledge and tools needed to navigate the advances in longevity care, assess emerging therapies, and implement technology for better patient outcomes.
This year’s event will highlight a diverse lineup of esteemed speakers who are pioneers in the field of longevity medicine. Among them is Dr. Amy Killen, Co-Founder and Chief Medical Officer of Humanaut Health, who will discuss insights from her upcoming book, "The Female Longevity Advantage." Dr. Elizabeth Yurth, Co-Founder and Chief Medical Officer at the Boulder Longevity Institute, will provide her expertise in regenerative and peptide medicine, while Dr. Tracy Gapin, author of "Doctor 2.0" and founder of the Peak Launch Institute, will share methodologies for physicians to enhance their practices with precision performance models.
The conference will not merely focus on traditional practices but will also delve into complex topics such as peptide therapy, the application of artificial intelligence in clinical settings, and how to turn intricate patient data into actionable medical decisions. Furthermore, CALM will address often-overlooked issues in aging medicine, such as women’s reproductive aging and hormone health, encouraging a holistic approach to longevity that encompasses various aspects of health.
In addition to dynamic presentations, CALM is structured to encourage active collaboration and networking among attendees. Practitioners will have opportunities to engage with peers, evaluate different approaches, and explore potential partnerships. This environment promotes continuous dialogue, vital for those who are committed to pushing the boundaries of longevity medicine.
Leonard Pastrana, PharmD, Co-Founder of nuBioAge, stated, "We built CALM for those delivering longevity medicine. As the industry shifts towards consumer involvement, we believe practitioners should lead this field with informed and progressive practices." The utmost aim is to empower attendees not just with information but also with confidence in their capabilities to enhance patient care through innovation and collaboration.
In its ongoing mission to foster advancements in longevity medicine, nuBioAge welcomes Biote as its Foundational Partner for CALM 2027. Biote emphasizes hormone optimization as a essential factor in longevity and wellness approaches.
The exhibit floor at the conference will feature an array of companies specializing in precision diagnostics, genomics, clinical technologies, and patient care systems. Notable participants include Dutch, Cleerly, IntellxxDNA, Luqra, and others, showcasing the latest innovations in longevity medicine.
With the rapid pace of discoveries and technologies in the longevity space, CALM 2027 serves as a crucial platform for those at the forefront of healthcare. Attendees will leave not only with enhanced clinical knowledge but also with a fortified network of collaborations and the strategies needed to build successful longevity practices. For those looking to be part of this transformative movement in health and well-being, further details about registration and event speakers can be found at www.wearecalm.life.
In summary, CALM 2027 aims to consolidate the best practices, technologies, and thought leaders in longevity medicine, ensuring that practitioners are well-prepared to provide exceptional care and lead the charge towards a healthier and longer lifespan for their patients.
As the industry becomes more consumer-focused, the necessity for medical professionals to stay ahead of developments is paramount. CALM, which stands for the Clinical Application of Longevity Medicine, is tailored specifically for healthcare providers such as physicians, nurse practitioners, pharmacists, and clinical leaders tasked with implementing longevity medicine into their practices. The conference is designed to equip these practitioners with the knowledge and tools needed to navigate the advances in longevity care, assess emerging therapies, and implement technology for better patient outcomes.
This year’s event will highlight a diverse lineup of esteemed speakers who are pioneers in the field of longevity medicine. Among them is Dr. Amy Killen, Co-Founder and Chief Medical Officer of Humanaut Health, who will discuss insights from her upcoming book, "The Female Longevity Advantage." Dr. Elizabeth Yurth, Co-Founder and Chief Medical Officer at the Boulder Longevity Institute, will provide her expertise in regenerative and peptide medicine, while Dr. Tracy Gapin, author of "Doctor 2.0" and founder of the Peak Launch Institute, will share methodologies for physicians to enhance their practices with precision performance models.
The conference will not merely focus on traditional practices but will also delve into complex topics such as peptide therapy, the application of artificial intelligence in clinical settings, and how to turn intricate patient data into actionable medical decisions. Furthermore, CALM will address often-overlooked issues in aging medicine, such as women’s reproductive aging and hormone health, encouraging a holistic approach to longevity that encompasses various aspects of health.
In addition to dynamic presentations, CALM is structured to encourage active collaboration and networking among attendees. Practitioners will have opportunities to engage with peers, evaluate different approaches, and explore potential partnerships. This environment promotes continuous dialogue, vital for those who are committed to pushing the boundaries of longevity medicine.
Leonard Pastrana, PharmD, Co-Founder of nuBioAge, stated, "We built CALM for those delivering longevity medicine. As the industry shifts towards consumer involvement, we believe practitioners should lead this field with informed and progressive practices." The utmost aim is to empower attendees not just with information but also with confidence in their capabilities to enhance patient care through innovation and collaboration.
In its ongoing mission to foster advancements in longevity medicine, nuBioAge welcomes Biote as its Foundational Partner for CALM 2027. Biote emphasizes hormone optimization as a essential factor in longevity and wellness approaches.
The exhibit floor at the conference will feature an array of companies specializing in precision diagnostics, genomics, clinical technologies, and patient care systems. Notable participants include Dutch, Cleerly, IntellxxDNA, Luqra, and others, showcasing the latest innovations in longevity medicine.
With the rapid pace of discoveries and technologies in the longevity space, CALM 2027 serves as a crucial platform for those at the forefront of healthcare. Attendees will leave not only with enhanced clinical knowledge but also with a fortified network of collaborations and the strategies needed to build successful longevity practices. For those looking to be part of this transformative movement in health and well-being, further details about registration and event speakers can be found at www.wearecalm.life.
In summary, CALM 2027 aims to consolidate the best practices, technologies, and thought leaders in longevity medicine, ensuring that practitioners are well-prepared to provide exceptional care and lead the charge towards a healthier and longer lifespan for their patients.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.